Prio Wealth Limited Partnership’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$8.19M Sell
25,430
-95
-0.4% -$31.1K 0.24% 76
2024
Q2
$7.98M Sell
25,525
-1,299
-5% -$382K 0.24% 76
2024
Q1
$7.63M Buy
26,824
+1,589
+6% +$465K 0.22% 80
2023
Q4
$7.27M Sell
25,235
-75
-0.3% -$20.4K 0.25% 73
2023
Q3
$6.8M Sell
25,310
-161
-0.6% -$40.2K 0.26% 72
2023
Q2
$5.66M Sell
25,471
-15
-0.1% -$3.48K 0.2% 79
2023
Q1
$6.16M Sell
25,486
-630
-2% -$155K 0.24% 74
2022
Q4
$6.86M Buy
26,116
+296
+1% +$79.3K 0.27% 75
2022
Q3
$5.82M Sell
25,820
-572
-2% -$139K 0.25% 78
2022
Q2
$6.42M Buy
26,392
+168
+0.6% +$41.2K 0.26% 76
2022
Q1
$6.34M Sell
26,224
-780
-3% -$179K 0.21% 80
2021
Q4
$6.08M Sell
27,004
-498
-2% -$105K 0.19% 81
2021
Q3
$5.85M Sell
27,502
-1,786
-6% -$411K 0.2% 84
2021
Q2
$7.14M Sell
29,288
-3,244
-10% -$798K 0.24% 77
2021
Q1
$8.09M Sell
32,532
-4,513
-12% -$1.08M 0.29% 75
2020
Q4
$8.52M Sell
37,045
-623
-2% -$144K 0.32% 68
2020
Q3
$9.57M Buy
37,668
+718
+2% +$178K 0.4% 63
2020
Q2
$8.71M Sell
36,950
-325
-0.9% -$74.2K 0.4% 60
2020
Q1
$7.56M Sell
37,275
-6,216
-14% -$1.36M 0.42% 63
2019
Q4
$10.5M Sell
43,491
-1,875
-4% -$413K 0.44% 60
2019
Q3
$8.78M Sell
45,366
-25
-0.1% -$4.8K 0.4% 67
2019
Q2
$8.36M Sell
45,391
-2,244
-5% -$402K 0.38% 68
2019
Q1
$9.05M Sell
47,635
-602
-1% -$115K 0.42% 66
2018
Q4
$9.39M Sell
48,237
-2,962
-6% -$578K 0.5% 55
2018
Q3
$10.6M Buy
51,199
+1,299
+3% +$256K 0.48% 58
2018
Q2
$9.21M Sell
49,900
-1,016
-2% -$180K 0.46% 63
2018
Q1
$8.68M Sell
50,916
-2,456
-5% -$451K 0.43% 66
2017
Q4
$9.28M Sell
53,372
-1,296
-2% -$229K 0.43% 65
2017
Q3
$10.2M Sell
54,668
-2,482
-4% -$440K 0.5% 59
2017
Q2
$9.84M Sell
57,150
-604
-1% -$98.2K 0.49% 57
2017
Q1
$9.47M Buy
57,754
+7,320
+15% +$1.22M 0.49% 56
2016
Q4
$7.37M Sell
50,434
-8,572
-15% -$1.29M 0.39% 67
2016
Q3
$9.84M Sell
59,006
-1,100
-2% -$186K 0.52% 57
2016
Q2
$9.14M Sell
60,106
-175
-0.3% -$27.2K 0.5% 60
2016
Q1
$9.04M Sell
60,281
-2,170
-3% -$322K 0.49% 60
2015
Q4
$10.1M Sell
62,451
-914
-1% -$144K 0.55% 56
2015
Q3
$8.76M Sell
63,365
-462
-0.7% -$72.8K 0.5% 62
2015
Q2
$9.8M Sell
63,827
-3,679
-5% -$589K 0.5% 63
2015
Q1
$10.8M Sell
67,506
-675
-1% -$106K 0.53% 61
2014
Q4
$10.9M Sell
68,181
-2,155
-3% -$336K 0.54% 60
2014
Q3
$9.88M Sell
70,336
-950
-1% -$124K 0.51% 60
2014
Q2
$8.44M Sell
71,286
-2,800
-4% -$324K 0.43% 68
2014
Q1
$9.14M Sell
74,086
-360
-0.5% -$43.7K 0.46% 63
2013
Q4
$8.49M Sell
74,446
-100
-0.1% -$11.4K 0.43% 69
2013
Q3
$8.34M Sell
74,546
-101
-0.1% -$11K 0.47% 64
2013
Q2
$7.36M Buy
+74,647
New +$7.75M 0.44% 73

Other funds holding AMGN

Prio Wealth Limited Partnership's AMGN Position: Q3 2024 in Review

Prio Wealth Limited Partnership reduced its Amgen (AMGN) stake by 0.37% in Q3 2024, selling an estimated $31.1K and leaving 25,430 shares worth $8.19M. The position accounts for 0.24% of the portfolio, ranked #76.

Prio Wealth Limited Partnership first reported a position in AMGN in Q2 2013 and has held it in 46 quarters since. The position peaked at $10.9M in Q4 2014. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Prio Wealth Limited Partnership held 25,430 shares of Amgen worth $8.19M as of Q3 2024.
  • Prio Wealth Limited Partnership sold 95 Amgen shares in Q3 2024, an estimated $31.1K.
  • Amgen made up 0.24% of Prio Wealth Limited Partnership's portfolio in Q3 2024, its #76 holding.
  • Prio Wealth Limited Partnership first reported a position in Amgen in Q2 2013 and has held it in 46 quarters since.
  • Prio Wealth Limited Partnership's Amgen position peaked at $10.9M in Q4 2014.
  • 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Prio Wealth Limited Partnership's 13F filing for Q3 2024, filed 21 Oct 2024.